General Information
Version
2.0
Revision date
2025-09-16
Product name
TRANS-NONACHLOR UNLABELED 100 UG/ML IN NONANE
1.2.2. Uses advised against
No additional information available
supplier name
Cambridge Isotope Laboratories, Inc
Emergency telephone
1-703-741-5970, 1-800-424-9300 24
Icons in SDS
Company Information
company name
Cambridge Isotope Laboratories, Inc
e-mail address of the competent person responsible for the Safety Data Sheet
cilsales@isotope.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H226, H304, H315, H319, H332, H336
Hazard statements
Code
Statements
H226
Flammable liquid and vapour
Section 2
SECTION 2: Hazards identification
GHS US classification Classification of the substance or mixture GHS US classification Flammable liquids Category 3 H226 Flammable liquid and vapor Acute toxicity (inhalation:dust,mist) Category 4 H332 Harmful if inhaled Skin corrosion/irritation Category 2 H315 Causes skin irritation Serious eye damage/eye irritation Category 2A H319 Causes serious eye irritation Specific target organ toxicity – Single exposure, Category 3, Narcosis H336 May cause drowsiness or dizziness Aspiration hazard Category 1 H304 May be fatal if swallowed and enters airways Full text of H statements : see section 16
2.2 Label elements
GHS US labeling
Signal word
Danger
Hazard statements
H226 - Flammable liquid and vapor H304 - May be fatal if swallowed and enters airways H315 - Causes skin irritation H319 - Causes serious eye irritation H332 - Harmful if inhaled H336 - May cause drowsiness or dizziness
Precautionary statements
P210 - Keep away from heat, hot surfaces, sparks, open flames and other ignition sources. No smoking. heat, hot surfaces, open flames, sparks P233 - Keep container tightly closed. P240 - Ground/Bond container and receiving equipment. P241 - Use explosion-proof electrical, lighting, ventilating equipment. P242 - Use only non-sparking tools. P243 - Take precautionary measures against static discharge. P261 - Avoid breathing dust, fume, gas, mist, spray, vapors. P264 - Wash Both hands thoroughly after handling. P271 - Use only outdoors or in a well-ventilated area. P280 - Wear protective clothing, protective gloves. P301+P310 - If swallowed: Immediately call a poison center or doctor. P302+P352 - If on skin: Wash with plenty of water. P303+P361+P353 - If on skin (or hair): Take off immediately all contaminated clothing. Rinse skin with water/shower. P304+P340 - If inhaled: Remove person to fresh air and keep comfortable for breathing. P305+P351+P338 - IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P312 - Call a poison center or doctor if you feel unwell. P321 - Specific treatment (see Hazard pictograms (CLP) on this label). P331 - Do NOT induce vomiting. P332+P313 - If skin irritation occurs: Get medical advice/attention. P337+P313 - If eye irritation persists: Get medical advice/attention. P362 - Take off contaminated clothing and wash before reuse. P370+P378 - In case of fire: Use Carbon dioxide, Dry chemical, Alcohol resistant foam, Water spray to extinguish. P403+P233 - Store in a well-ventilated place. Keep container tightly closed. P403+P235 - Store in a well-ventilated place. Keep cool. P405 - Store locked up. P501 - Dispose of contents/container to Comply with applicable regulations.
Other hazards which do not result in classification
No additional information available
Ingredient(s) with unknown acute toxicity
Not applicable
2.1 Classification of the substance or mixture
GHS US classification Flammable liquids Category 3 H226 Flammable liquid and vapor Acute toxicity (inhalation:dust,mist) Category 4 H332 Harmful if inhaled Skin corrosion/irritation Category 2 H315 Causes skin irritation Serious eye damage/eye irritation Category 2A H319 Causes serious eye irritation Specific target organ toxicity – Single exposure, Category 3, Narcosis H336 May cause drowsiness or dizziness Aspiration hazard Category 1 H304 May be fatal if swallowed and enters airways Full text of H statements : see section 16